Exane Derivatives’s Baxter International BAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BAX
GIM
VAM
Exane Derivatives's BAX Position: Q2 2022 in Review
Exane Derivatives sold out of Baxter International (BAX) in Q2 2022, closing a stake of 155 shares — an estimated $12K sold.
Exane Derivatives first reported a position in BAX in Q1 2017 and held it in 12 quarters. The position peaked at $770K in Q2 2019. 1,073 funds tracked by Wall St. Rank hold BAX as of Q2 2022.
- Exane Derivatives reported no remaining Baxter International position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 155 Baxter International shares in Q2 2022, an estimated $12K.
- Exane Derivatives first reported a position in Baxter International in Q1 2017 and held it in 12 quarters.
- Exane Derivatives's Baxter International position peaked at $770K in Q2 2019.
- 1,073 funds tracked by Wall St. Rank held Baxter International as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.